Clinical Trial Update: Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder [NA]

View source ↗

Summary

A NYU Langone Health-sponsored clinical trial is exploring regulatory-flexibility-enabled methadone take-home dosing to improve retention in opioid use disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Methadone (methadone)

Snippet

Sponsor: NYU Langone Health | Conditions: Problems Related to Social Environment | NA | Status: RECRUITING